Platecharacteristics:

Transparent

Contents:

• Coatingantibodies
• Biotinylateddetectorantibodies
• Phi-labeledgoatanti-biotinantibodies
• Activatorsolutions
• Blockingstocksolution
• DilutionbufferT
• Tween-20
• TransparentELISPOTplateswithlidsandcoverslips
• Detailedmanual

Referenceslist:

• AutoreactiveTcellresponsesshowproinflammatorypolarizationindiabetesbutaregulatoryphenotypeinhealth.Arif,Sefina,etal.J.Clin.Invest.2004Feb;113:451-63
• Self-glycolipidsmodulatedendriticcellschangingthecytokineprofilesofcommittedautoreactiveTcells.Buschard,Karsten,etal.PLoSONE2012;7:e52639
• Developmentoftype1diabetesdespiteseverehereditaryB-lymphocytedeficiency.Martin,S,etal.N.Engl.J.Med.2001Oct4;345:1036-40
• DevelopmentofnovelLL-37derivedantimicrobialpeptideswithLPSandLTAneutralizingandantimicrobialactivitiesfortherapeuticapplication.Nell,MarjaJ,etal.Peptides2006Apr;27:649-60
• AssociationofT-cellreactivitywithbeta-cellfunctioninrecentonsettype1diabetespatients.Pfleger,Christian,etal.J.Autoimmun.2010Mar;34:127-35
• Beta-cellfunctioninnew-onsettype1diabetesandimmunomodulationwithaheat-shockproteinpeptide(DiaPep277):arandomised,double-blind,phaseIItrial.Raz,I,etal.Lancet2001Nov24;358:1749-53
• IsletantigenspecificIL-10+immuneresponsesbutnotCD4+CD25+FoxP3+cellsatdiagnosispredictglycemiccontrolintype1diabetes.Sanda,Srinath,etal.Clin.Immunol.2008May;127:138-43
• CD8T-cellreactivitytoisletantigensisuniquetotype1whileCD4T-cellreactivityexistsinbothtype1andtype2diabetes.Sarikonda,Ghanashyam,etal.J.Autoimmun.2014May;50:77-82
• ComparisonofcytokineELISpotassayformatsforthedetectionofisletantigenautoreactiveTcells.ReportofthethirdimmunologyofdiabetessocietyT-cellworkshop.Schloot,NanetteC,etal.J.Autoimmun.2003Dec;21:365-76
• AutoantibodiesandassociatedT-cellresponsestodeterminantswithinthe831-860regionoftheautoantigenIA-2inType1diabetes.Weenink,SM,etal.J.Autoimmun.2009Sep;33:147-54
• Humanmesenchymalstemcellsmodulatecellularimmuneresponsetoisletantigenglutamicaciddecarboxylaseintype1diabetes.Zanone,MariaM,etal.J.Clin.Endocrinol.Metab.2010Aug;95:3788-97
• RedirectionofhumanautoreactiveT-cellsUponinteractionwithdendriticcellsmodulatedbyTX527,ananalogof1,25dihydroxyvitaminD(3).vanHalteren,AstridGS,etal.Diabetes2002Jul;51:2119-25

U-CyTech研究与开发我们的科学团队在针对各种应用（人类，猴子，大鼠和小鼠）开发和优化各种免疫测定方法方面拥有丰富的经验。我们是与他人（生物）技术和（生物）制药公司及大学合作开展的分析开发项目的领先公司。U-CyTech提供各种体外测定法来检测细胞因子和其他分析物。 U-CyTech具有广泛的专业知识，并具有以下能力：开发特定的ELISA  分析开发特定的ELISPOT分析定制和生产试剂盒检测此外，我们还根据客户的个人需求提供实验室合同服务。 合同服务包括：特异性ELISA / ELISPOT测定方法开发常规ELISA / ELISPOT分析测试基于CPE的抗病毒分析（AVA）测试化验咨询和故障排除服务值得注意的是，我们的分析开发服务使您能够利用我们“内部”试剂供应的优势，从而以可靠，可重复且经济高效的方式加快分析开发速度。 U-CyTech提供快速处理，准确可靠的结果。经验丰富的科学家定期进行联系并提供进度报告，可以使您实时了解工作进展。如果需要，客户还将收到一份书面报告（或报告的电子副本为PDF）。定制化验是在非排他性安排下开发的，U-CyTech保留将新开发的化验添加为服务组合一部分的权利。